top of page
1938512.jpg

IKRIS PHARMA

Home: Welcome

A combined regimen of Apatinib plus Gefitinib

According to the outcomes from the phase 3 ACTIVE trial, the frontline treatment with the drug apatinib together with gefitinib has been...

All you need to know about Imatinib

Imatinib is a member of the class of TKI (tyrosine kinase inhibitor) that mainly inhibits the activity of bcr-abl fusion protein,...

Acute Lymphoblastic Leukemia

Introduction: Acute Lymphoblastic Leukemia may be called by other names, including ALL and acute lymphoid leukemia. ALL can occur at any...

ALK-Positive Lung Cancer- A complete Guide

What is ALK-positive lung cancer? ALK-positive is basically known as an abnormal rearrangement of the anaplastic lymphoma kinase (ALK)...

Drugs That Holds Tomorrow Of Myeloma Patients

Drug therapy in order to kill the myeloma cells is the main therapy for myeloma patients who need treatment. Some of the drugs which are...

All about Benign Prostatic Hyperplasia (BPH)

The most common benign tumor that is found in men is characterized by the term Benign Prostatic Hyperplasia. To describe in simple words,...

A complete discussion on Carmustine

The drug is indicated as the palliative therapy as a single agent or in established combination therapy with the several other approved...

All you need to know about Nintedanib

Nintedanib is a class of medication known as tyrosine-kinase inhibitors and anti-fibrotic agents. It basically affects your immune system...

Indications and Dosage of Ribociclib

Indication: Kryxana contains the active substance ribociclib, which belongs to a group of medicines called cyclin-dependent kinase (CDK)...

Home: Blog2

Subscribe Form

Stay up to date

Thanks for submitting!

Home: Subscribe

Subscribe Form

Thanks for submitting!

  • Facebook
  • Twitter
  • LinkedIn

©2020 by Ikris Pharma. Proudly created with Wix.com

bottom of page